Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran PK/PD in Moderate Renal Impairment for Hip/Knee Replacement
NCT01184989Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Aug 2010; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01184989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184989.